Publications

Publications, Books, Book Chapters and Reviews by Prof. Marcus Maurer, MD

Use: Start with an overview of all publications. Use tag links to list selected documents or to list an entire category, e.g. Original Work, Books, Book Chapters, Reviews. If you know what you are looking for, enter this term in the search field.

[o.152b] Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: a critical appraisal (0)
[o.242] Omalizumab for the treatment of chronic spontaneous urticaria: a meta-analysis of randomized clinical trials (1)
[o.423] Omalizumab in children and adolescents with chronic urticaria: a 16 week real-world study (0)
[o.421] Omalizumab in chronic inducible urticaria: a real-life study of efficacy, safety, predictors of treatment outcome and time to response (2)
[o.163] Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy (0)
[o.180] Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis (2)
[o.631] Omalizumab is effective and safe in chronic inducible urticaria (CIndU): real-world data from a large multi-national UCARE study (0)
[o.283] Omalizumab is effective in cold urticaria – results of a randomized, placebo controlled trial (6)
[o.427] Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria (2)
[o.282] Omalizumab is effective in symptomatic dermographism – results of a randomized, placebo controlled trial (6)
[o.228] Omalizumab may not inhibit mast cell and basophil activation in vitro (3)
[o.339] Omalizumab normalizes the gene expression signature of lesional skin in patients with chronic spontaneous urticaria: A randomized, double‐blind, placebo‐controlled study (2)
[o.298] Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study data (2)
[o.281] Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria (2)
[o.410] Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both (1)
[o.338] On the Lipophilic Nature of Autoreactive IgE in Chronic Spontaneous Urticaria (2)
[o.550] One in five patients with chronic spontaneous urticaria has IgE to tissue transglutaminase 2 (0)
[o.590] Online depiction of urticaria is often flawed and does not reflect the spectrum of clinical manifestation (0)
[o.179] Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedema (0)
[o.654] Oral deucrictibant for on-demand treatment of hereditary angioedema attacks (RAPIDe-1): a randomised, double-blind, placebo-controlled, phase 2 trial. (0)

« Previous
1
…
20
21
22
23
24
…
34
Next »

(Last update: 06.2026)

Number of original publications in peer-reviewed journals:	662
Number of reviews in peer-reviewed journals:	231
Number of publications (original work and reviews) in peer-reviewed journals:	893
Cumulative IF for original publications in peer-reviewed journals:	4768.99
Cumulative IF for reviews in peer-reviewed journals:	1703.12
Cumulative IF of publications (original work & reviews) in peer-reviewed journals:	6472.11
Total number of citations: 45,522 h-index: 109 (Web of Science July 2025)	45,522

Download-Information

To be able to download the offered contents, you have to login. If you do not know the login, please write me your request.